Neural Therapeutics Inc. (NURL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 165 | 67 | 273 | 372 | 0 |
| Receivables | 7 | 28 | 69 | 51 | 1,229 |
| TOTAL | $192 | $94 | $351 | $455 | $1,229 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 2 | 0 | 0 | 0 |
| TOTAL | $0 | $2 | $0 | $0 | $0 |
| Total Assets | $192 | $96 | $351 | $455 | $1,229 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 11 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 30 | 87 | 197 | 179 | 55 |
| Accrued Expenses | 145 | 208 | 276 | 149 | 215 |
| TOTAL | $175 | $306 | $473 | $464 | $270 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 745 | 474 | 140 | 0 | 0 |
| TOTAL | $745 | $474 | $140 | $0 | $0 |
| Total Liabilities | $920 | $780 | $613 | $464 | $270 |
| Shareholders' Equity | |||||
| Common Shares | 3,547 | 2,913 | 2,315 | 2,068 | 1,536 |
| Retained earnings | -5,163 | -4,137 | -3,471 | -2,395 | -576 |
| Other shareholders' equity | 791 | 540 | 894 | 318 | 0 |
| TOTAL | $-728 | $-684 | $-262 | $-9 | $959 |
| Total Liabilities And Equity | $192 | $96 | $351 | $455 | $1,229 |